IP Library Granted Patent US 10,196,676
Granted Patent B2
US 10,196,676 · App. 16/046,669 · Granted Feb 5, 2019

Isolation of nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,196,676
App. No.
16/046,669
Granted
Feb 5, 2019
Kind
B2
Abstract

Provided herein is technology relating to isolating nucleic acids. In particular, the technology relates to methods and kits for extracting nucleic acids from problematic samples such as stool.

Claims (15)

1. A method for isolating a human target DNA from a fluid fraction prepared from human stool homogenate for use in a nucleic acid detection reaction, the method comprising:

i) treating a fluid fraction from a human stool homogenate with insoluble polyvinylpyrrolidone to bind inhibitor, if present, in an insoluble inhibitor complex, to produce a treated stool fluid;

ii) exposing the treated stool fluid to a target sequence-specific capture reagent comprising particles attached to oligonucleotides complementary to at least a portion of human target DNA, under conditions wherein the target sequence-specific capture reagent forms a target sequence-specific capture reagent/human target DNA capture complex,

iii) separating the capture complex from said treated stool fluid;

iv) recovering human target DNA from the capture complex in a human target DNA solution; and

v) performing a DNA detection reaction on said human target DNA solution.

2. The method of claim 1 , further comprising:

vi) retaining residual treated stool fluid after said separating said capture complex in iii); and

vii) repeating the exposing, separating, and recovering of steps ii) to iv) using the residual treated stool fluid and a second target sequence-specific capture reagent that is specific for a second human target DNA.

3. The method of claim 1 , wherein said insoluble polyvinylpyrrolidone is provided as a capsule or pressed tablet comprising a premeasured amount of insoluble polyvinylpyrrolidone.

4. The method of claim 1 , wherein treating said fluid fraction from a human stool homogenate with insoluble polyvinylpyrrolidone to produce said treated stool fluid comprises passing treated stool fluid through porous filtering material, wherein the insoluble inhibitor complex is retained by the porous filtering material.

5. The method of claim 1 , wherein said particle of said target-specific capture reagent comprises a magnetic particle and wherein said separating said capture complex comprises exposing said capture complex to a magnetic field.

6. The method of claim 1 , wherein recovering said human target DNA comprises eluting said human target DNA from said capture complex.

7. The method of claim 1 , wherein said nucleic acid detection reaction comprises use of at least one enzyme selected from the group consisting of a restriction endonuclease, a flap endonuclease, a reverse transcriptase, a ligase, an RNA polymerase, and a DNA polymerase.

8. The method of claim 7 , wherein said nucleic acid detection reaction comprises a polymerase chain reaction.

Assignments (3)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0249) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0393 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 1, 2018
From: BRUINSMA, JANELLE J.; DOMANICO, MICHAEL J.; LIDGARD, GRAHAM P.; ZOU, HONGZHI; WEISBURG, WILLIAM G.; SHENOI, HEMANTH D.; LIGHT, JAMES P., II; KOPITZKE, KEITH; ZEIS, JOHN
To: EXACT SCIENCES CORPORATION
Reel/Frame 046521/0523 →